Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Akriti Seth
An IQVIA report dives into how technology can facilitate a digital future for value added medicines, while discussing the market size, opportunities, scope of growth and challenges for this emerging sector in healthcare.
The first Serious Shortage Protocol has been issued by the DHSC to tackle supply disruptions for fluoxetine capsules. The protocol came into effect on 3 October 2019 and will expire at the end of the month.
Teva has announced a leadership change in its global operations, while Lupin has made a key appointment to focus on quality and compliance. Among other changes in leadership roles, Olainfarm has seen one of its six management board members resign.
The UK’s CMA has accused Tiofarma and Amilco of colluding with Aspen over an illegal agreement that resulted in significant price hikes for fludrocortisone.
The National Audit Office’s recent report on Brexit throws light on the government’s health-related preparations for a no-deal Brexit, including DHSC efforts to build up stocks and re-route supplies.
An ASBM survey of 575 biologic prescribers in six western European countries has found that 90% of physicians are familiar with biosimilars, compared to 76% in 2013. The results were presented and discussed at the 2019 ESMO Congress.